{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:44:51Z","timestamp":1788587091528,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.atherosclerosis.2008.12.009","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T08:22:48Z","timestamp":1229415768000},"page":"8-16","source":"Crossref","is-referenced-by-count":45,"title":["Surrogate markers in clinical trials\u2014Challenges and opportunities"],"prefix":"10.1016","volume":"206","author":[{"given":"Rapha\u00ebl","family":"Duivenvoorden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.G.","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.P.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/092986708783955482","article-title":"Novel molecules targeting dyslipidemia and atherosclerosis","volume":"15","author":"Tavridou","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1056\/NEJMp0803740","article-title":"Redefining quality-implications of recent clinical trials","volume":"358","author":"Krumholz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02333016","article-title":"Surrogate endpoints: a basis for a rational approach","volume":"43","author":"Boissel","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/cs0930317","article-title":"Reproducibility of ultrasonographic measurements of different carotid and femoral artery segments in healthy subjects and in patients with increased intima-media thickness","volume":"93","author":"Smilde","year":"1997","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","article-title":"Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study","volume":"90","author":"Kannel","year":"1979","journal-title":"Ann Intern Med"},{"issue":"Suppl. A","key":"10.1016\/j.atherosclerosis.2008.12.009_bib8","first-page":"5A","article-title":"Cholesterol and lipids in the risk of coronary artery disease\u2014the Framingham Heart Study","volume":"4","author":"Castelli","year":"1988","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1373\/clinchem.2008.104893","article-title":"After ENHANCE: is more LDL cholesterol lowering even better?","volume":"54","author":"Stein","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(00)04053-8","article-title":"Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial","volume":"357","author":"Smilde","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib16","first-page":"229","article-title":"Increasing HDL cholesterol with extended release nicotinic acid: from promise to practice","volume":"62","author":"Birjmohun","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib17","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib18","unstructured":"Vergeer M, Bots ML, van Leuven SI, et al. The CETP inhibitor torcetrapib and off-target toxicity: a pooled analysis of the RADIANCE trials. Circulation; in press."},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bjp.2008.229","article-title":"Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone","volume":"154","author":"Forrest","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"Suppl. 1 (10)","key":"10.1016\/j.atherosclerosis.2008.12.009_bib20","first-page":"A322","article-title":"Absence of effect of R1658\/JTT-705 on blood pressure and tissue expression of renin-angiotensin system related genes in rats","volume":"51","author":"Stroes","year":"2008","journal-title":"J Am College Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib22","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib23","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib24","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJMp078167","article-title":"The rosiglitazone story\u2014lessons from an FDA advisory committee meeting","volume":"357","author":"Rosen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.83.3.913","article-title":"Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens","volume":"83","author":"Tobis","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib27","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib29","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.0000034508.55617.65","article-title":"ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness","volume":"106","author":"Taylor","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib30","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa071359","article-title":"Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia","volume":"356","author":"Kastelein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(07)61088-5","article-title":"Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial","volume":"370","author":"Bots","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ahj.2005.10.025","article-title":"Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study","volume":"152","author":"Nicholls","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib35","first-page":"382","article-title":"Effect of ACAT inhibition on progression of carotid atherosclerosis in patients with familial hypercholesterolemia, the CAPTIVATE study","volume":"1","author":"Meuwese","year":"2007","journal-title":"J Clin Lipidol"},{"issue":"September (12)","key":"10.1016\/j.atherosclerosis.2008.12.009_bib36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000142048.94084.CA","article-title":"Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries","volume":"110","author":"von Birgelen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.74.6.1399","article-title":"Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging","volume":"74","author":"Pignoli","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib39","doi-asserted-by":"crossref","first-page":"54C","DOI":"10.1016\/S0002-9149(99)80471-8","article-title":"Lipids, and atherosclerosis in the carotid arteries (PLAC-II)","volume":"76","author":"Byington","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9149(99)80580-3","article-title":"Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)","volume":"75","author":"Crouse","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/0003-4819-124-6-199603150-00002","article-title":"Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial","volume":"124","author":"Hodis","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib42","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/01.CIR.97.18.1784","article-title":"Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group","volume":"97","author":"MacMahon","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib43","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(98)00170-3","article-title":"B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)","volume":"31","author":"de Groot","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib44","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.90.4.1679","article-title":"Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic carotid Artery Progression Study (ACAPS) Research Group","volume":"90","author":"Furberg","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib45","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.CIR.103.13.1721","article-title":"Low-dose metoprolol CR\/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS)","volume":"103","author":"Hedblad","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0002-9343(96)00333-6","article-title":"Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study","volume":"101","author":"Mercuri","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib47","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/01.CIR.92.7.1758","article-title":"Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries","volume":"92","author":"Salonen","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib48","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.297.12.1344","article-title":"Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial","volume":"297","author":"Crouse","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MOL.0b013e3282f19608","article-title":"Atherosclerosis imaging as a benchmark in the development of novel cardiovascular drugs","volume":"18","author":"Duivenvoorden","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib50","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib52","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2008.02.044","article-title":"Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation","volume":"51","author":"Donald","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib53","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1161\/CIRCULATIONAHA.106.678276","article-title":"Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study","volume":"115","author":"Yeboah","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib54","doi-asserted-by":"crossref","first-page":"936","DOI":"10.7326\/0003-4819-121-12-199412150-00005","article-title":"Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women","volume":"121","author":"Lieberman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.HYP.33.1.575","article-title":"Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension","volume":"33","author":"Muiesan","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib57","first-page":"83","article-title":"Effect of a short-term primary prevention program on endothelium-dependent vasodilation in adults at risk for atherosclerosis","volume":"15","author":"Jodoin","year":"1999","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib58","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1161\/CIRCULATIONAHA.105.583195","article-title":"Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy: the Special Turku Coronary Risk Factor Intervention Project for children (STRIP)","volume":"112","author":"Raitakari","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib59","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1161\/CIRCULATIONAHA.104.528174","article-title":"In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology","volume":"112","author":"Cai","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1148\/radiol.2412051336","article-title":"Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study","volume":"241","author":"Kerwin","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib61","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jmri.10294","article-title":"Volume-selective 3D turbo spin echo imaging for vascular wall imaging and distensibility measurement","volume":"17","author":"Crowe","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib62","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jacc.2004.12.026","article-title":"Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging","volume":"45","author":"Wentzel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jmri.20562","article-title":"Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3Tesla magnetic field strengths","volume":"23","author":"Yarnykh","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib64","unstructured":"Duivenvoorden R, de Groot E, Elsen BM, et al. In vivo quantification of carotid artery wall dimensions: 3.0Tesla MRI versus B-mode ultrasound imaging. Circulation Cardiovascular Imaging; in press."},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.CIR.104.3.249","article-title":"Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib66","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/01.CIR.0000041255.88750.F0","article-title":"Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years\u2019 follow-up by high-resolution noninvasive magnetic resonance imaging","volume":"106","author":"Corti","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib67","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.0000145170.22652.51","article-title":"Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy","volume":"110","author":"Lima","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib68","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacc.2004.11.039","article-title":"Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging","volume":"45","author":"Yonemura","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib69","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.atherosclerosis.2007.09.001","article-title":"Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging","volume":"197","author":"Lee","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib70","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/hq1001.098463","article-title":"Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case\u2013control study","volume":"21","author":"Zhao","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib71","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ahj.2007.11.018","article-title":"Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial","volume":"155","author":"Underhill","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2008.12.009_bib72","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.ATV.0000012662.29622.00","article-title":"Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study","volume":"22","author":"Jaffer","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500800899X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500800899X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T05:31:58Z","timestamp":1557984718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191500800899X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S002191500800899X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.12.009","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}